FILE PHOTO: A drone view shows the Eli Lilly logo on one of the company’s offices in San Diego, California, U.S., November 21, 2025. REUTERS/Mike Blake/File Photo Feb 18 (Reuters) - Australia's CSL ...
(RTTNews) - CSL Ltd. (CSL, CSLLY, CSL.AX, CMXHF.PK) Monday announced that its subsidiary CSL Seqirus finalized a global collaboration and license agreement with Arcturus Therapeutics Holdings Inc ...
Genezen reports that the company became the first CDMO to license CSL’s Cytegrity™ cell line production system that was designed for the production of lentiviral vectors (LVVs). “We have significant, ...
CSL Ltd. subsidiary CSL Seqirus signed a licensing and development deal with Arcturus Therapeutics Inc. to in-license Arcturus’ late-stage self-amplifying mRNA vaccine platform technology. Arcturus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results